Skip to main content
. 2021 Oct 7;5(Suppl 2):e12589. doi: 10.1002/rth2.12589
PK‐guided dosing Yes (n = 16) PK‐guided dosing No (n = 56)
ABR, mean (SD) 1.6 (1.1) 4.4 (2.8)
Presence of target joints, n (%) 7 (43.8) 30 (53.6)
Number of target joints, mean (SD) 0.6 (0.8) 1.2 (1.5)
Presence of problem joints, n (%) 11 (68.8) 29 (51.8)
Number of problem joints mean (SD) 1.1 (0.9) 0.9 (1.2)

ABR, annualized bleeding rate; NS, not significant; PK, pharmacokinetic.